Cyltezo

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 0597-0405
  • Package NDC 0597-0405-80
  • Application number BLA761058
  • SPL ID e7565b3d-b98e-46bb-906f-e821077068dc
  • SPL set ID 115ea79b-7209-7f19-b35d-36ec0828fbf5
  • RxCUI 797544
  • RxCUI 2640883
  • RxCUI 2640889
  • RxCUI 2640891
  • RxCUI 2640892
  • RxCUI 2640893
  • RxCUI 2640894
  • RxCUI 2640895
  • RxCUI 2640898
  • RxCUI 2640900
  • RxCUI 2640901
  • RxCUI 2640902
  • RxCUI 2640903
  • RxCUI 2680743
  • RxCUI 2680746
  • RxCUI 2680748
  • RxCUI 2680750
  • RxCUI 2680756
  • RxCUI 2680757
  • RxCUI 2680759
  • RxCUI 2680760

What the source publishes

Labeler
Boehringer Ingelheim Pharmaceuticals, Inc.
Active ingredients
adalimumab-adbm
Form
KIT
Administrative status
present-in-source-snapshot
Marketing status
BLA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:0597-0405_e7565b3d-b98e-46bb-906f-e821077068dc
{
  "name": "Cyltezo",
  "splId": "e7565b3d-b98e-46bb-906f-e821077068dc",
  "labels": [
    {
      "setId": "115ea79b-7209-7f19-b35d-36ec0828fbf5",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=115ea79b-7209-7f19-b35d-36ec0828fbf5",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=115ea79b-7209-7f19-b35d-36ec0828fbf5"
    }
  ],
  "routes": [],
  "labeler": "Boehringer Ingelheim Pharmaceuticals, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "2 KIT in 1 CARTON (0597-0405-80)  / 1 KIT in 1 KIT *  1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE *  2 PACKET in 1 TRAY / 1 mL in 1 PACKET",
      "package_ndc": "0597-0405-80",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20230701"
    }
  ],
  "productId": "0597-0405_e7565b3d-b98e-46bb-906f-e821077068dc",
  "useDomain": "unknown",
  "dosageForm": "KIT",
  "productNdc": "0597-0405",
  "deaSchedule": null,
  "genericName": "adalimumab-adbm",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [],
  "applicationNumber": "BLA761058",
  "marketingCategory": "BLA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20230701",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "rxcui": [
      "797544",
      "2640883",
      "2640889",
      "2640891",
      "2640892",
      "2640893",
      "2640894",
      "2640895",
      "2640898",
      "2640900",
      "2640901",
      "2640902",
      "2640903",
      "2680743",
      "2680746",
      "2680748",
      "2680750",
      "2680756",
      "2680757",
      "2680759",
      "2680760"
    ],
    "spl_set_id": [
      "115ea79b-7209-7f19-b35d-36ec0828fbf5"
    ],
    "manufacturer_name": [
      "Boehringer Ingelheim Pharmaceuticals, Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:0597-0405_e7565b3d-b98e-46bb-906f-e821077068dc"